Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.45 USD | +1.30% | -3.86% | -29.30% |
Apr. 15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
Feb. 26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.30% | 1.44B | |
-17.60% | 11.52B | |
+39.11% | 3.27B | |
-20.67% | 2.02B | |
+11.45% | 1.01B | |
-6.33% | 719M | |
-30.75% | 418M | |
-51.02% | 339M | |
-2.58% | 284M | |
+25.57% | 240M |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- Needham Adjusts Price Target on Veracyte to $33 From $31, Maintains Buy Rating